IDT Biologika News

Read about the latest news and developments at IDT Biologika, including the company’s growth, innovations and community involvement.
You can also access our entire archive of press releases and follow our activity on social media.

IDT Biologika to concentrate on human vaccines and pharmaceuticals more info

Ceva Santé Animale and IDT Biologika GmbH more info

CMO Leadership Awards 2019 more info

Federal Minister of Health Jens Spahn and Prime Minister Reiner Haseloff visit IDT Biologika

Monday, 19. April 2021

Dessau-based company to now fill AstraZeneca COVID-19 vaccine - Merz Pharma is foregoing capacities at short notice more info

IDT Biologika lays foundations for new multifunctional vaccine production building

Thursday, 8. April 2021

Overall, a total of 100 million euros are currently being invested in the site... more info

IDT Biologika and Takeda support production of the Johnson & Johnson single-shot COVID-19 vaccine

Monday, 15. March 2021

Takeda provides booked capacity at the IDT site in Dessau more info

Start of second study phase of vector vaccine against COVID-19 postponed

Monday, 11. January 2021

Initial data for corona vaccine indicate good tolerability but weak immune response more info

Federal Minister of Health visits IDT Biologika

Tuesday, 24. November 2020

5 million vaccine doses against COVID-19 more info

Corporate Communications

If you are a journalist and have any questions, please don't hesitate to contact us.

Kontaktformular

Ulrich Gartner

Gartner Communications